DiagnaMed Holdings Corp.
0.03
CAD
+0.00
(-14.29%)
ISIN
CA25245D1033
CUSIP
25245D103
Return %
Stock
S&P 500
1Y
-71.43
14.20
3Y
-14.29
81.12
5Y
- -
68.34
Capital Structure
CAD
•
in mil. unless spec.Working Capital
CAD
•
in mil. unless spec.Growth Rates
CAD
•
in mil. unless spec.Quarterly Revenue
CAD
•
in mil. unless spec.Quarterly Earnings Per Share
CAD
•
in mil. unless spec.Quarterly Dividends Per Share
CAD
•
in mil. unless spec.Company Description
- CEO
- John Ioannis Karagiannidis
- Full Time Employees
- 5
- Sector
- Health technology
- Industry
- Biotechnology
- Address
- 82 Richmond Street East Toronto ON Canada M5C 1P1
- IPO Date
- Nov 8, 2022
- Website
- diagnamed.com
- Similar Companies
- Business
- DiagnaMed Holdings Corp. DiagnaMed Holdings Corp. (CSE: DMED) operates as a Canadian clean-technology company focused on the discovery and production of naturally occurring geologic, or white, hydrogen, alongside residual activities in AI-based brain health diagnostics; its core offerings encompass proprietary soil-gas survey methods and subsurface analytics for hydrogen identification in favorable geological settings, patented Heatwave electromagnetic stimulation tools via exclusive partnership with TerraVent Environmental Inc. for non-electrolytic extraction from iron-rich rock formations and depleted hydrocarbon reservoirs, and legacy prescription digital therapeutic products including BrainYear, an electroencephalogram-based machine-learning solution for brain age detection, and BrainTremor for neurological disorder assessment. The company targets industrial, municipal, and transportation sectors in the clean energy market, with operations centered in Ontario and Québec along the proposed Natural Hydrogen Corridor, leveraging existing energy infrastructure for low-cost, low-emission production that supports global decarbonization goals. Founded in 2020 and headquartered in Vancouver, British Columbia, with prior references to Toronto, DiagnaMed integrates discovery and extraction into a unified platform to minimize environmental impact. In recent developments, DiagnaMed launches its Ontario Natural Hydrogen and Helium Exploration Program in the Timiskaming District during 2025, confirming widespread hydrogen anomalies exceeding 2,000 parts per million through extensive soil sampling; it announces a strategic collaboration with TerraVent Environmental Inc. on January 22, 2025, for next-generation clean hydrogen extraction, strengthens leadership with a new CEO appointment and CFO transition in mid-2025, completes major soil sampling programs with Quebec Innovative Materials Corp. (QIMC) revealing hydrogen zones expanded over 11 kilometers, signs a Memorandum of Understanding with Témiscamingue First Nation for hydrogen development along the Ontario-Québec border, and acquires strategic Ontario claims adjacent to QIMC assets to bolster its position in promising natural hydrogen regions.
Company News
Black Pine Resources Announces Closing of Qualifying Transaction